Introduction
Therapeutic drug monitoring Market is rapidly emerging as a cornerstone of precision medicine, enabling clinicians to tailor drug dosages by measuring concentrations of medications in patients’ biological fluids. As narrow-therapeutic-index drugs become more common in areas such as oncology, autoimmune disorders, and transplant medicine, the need for accurate, timely monitoring is growing. According to the Mordor Intelligence analysis,
The therapeutic drug monitoring market reached USD 1.36 billion in 2025 and is forecast to attain USD 2.11 billion by 2030, advancing at a 9.12% CAGR. This therapeutic drug monitoring market growth is being underpinned by several key forces: the adoption of decentralized clinical-trial models, the integration of pharmacogenomics with dose decision tools, and innovations in sampling such as dried-blood-spot testing. As clinical laboratories look for ways to increase throughput and reduce cost, the shift toward automation and high-volume testing is also boosting demand. Meanwhile, regulatory developments are helping improve quality and payer acceptance of broader test panels.
Key Trends
Rising Demand in Precision Medicine
One of the most influential trends driving the therapeutic drug monitoring market is the increasing adoption of precision medicine. As cancer therapies, HIV treatments, and biologics become more complex and individualized, clinicians require tight control of drug levels to maximize efficacy and minimize toxicity.
Emerging Sample Collection Methods
Traditional blood sampling techniques are being complemented and, in some cases, replaced by novel methods such as dried-blood-spot sampling and decentralized biosensor platforms. These innovations make therapeutic drug monitoring more accessible, especially for remote or resource-limited settings. Dried-blood-spot sampling reduces reliance on central lab infrastructure and allows remote dose titration, while biosensor-based devices and wearables offer real-time or near-real-time drug-level tracking.
Lab Automation and High-Throughput Testing
To handle increasing test volumes and cost pressures, hospitals and diagnostic labs are adopting high-throughput automation. Core labs are integrating immunoassays and LC-MS/MS analyzers into automated lines, improving efficiency, and reducing turnaround times.
Regulatory and Reimbursement Alignment
Regulatory clarity and payer support are emerging as important enablers for market growth. For instance, phased FDA oversight of lab-developed tests is raising quality standards, while alignment of reimbursement pathways is helping payers recognize the value of expanded TDM panels.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
Market Segmentation
The therapeutic drug monitoring market can be understood through several critical segments:
By Technology
-
Immunoassays
-
Chromatography (GC, HPLC)
-
Biosensor-Based & Wearables
-
Other Technologies
By Drug Class
-
Antiarrhythmic Drugs
-
Antiepileptic Drugs
-
Immunosuppressants
-
Antibiotics (e.g., Vancomycin, Aminoglycosides)
-
Antipsychotics & Mood Stabilizers
-
Oncology & Targeted Therapies
-
Other Drug Classes
By End-user
-
Hospital Laboratories
-
Independent / Reference Laboratories
-
Academic & Research Institutes
-
Point-of-Care / Patient Self-Testing
-
Contract Research & CRO Labs
By Geography
-
North America
-
South America
-
Europe
-
Middle east&Africa
-
Asia pacific
Key Players
Several established diagnostics and life-science firms are leading the competitive landscape in the therapeutic drug monitoring market:
-
Thermo Fisher Scientific
-
Bio-Rad Laboratories
-
F. Hoffmann-La Roche Ltd
-
Danaher Corporation (Beckman Coulter, Inc.)
-
Siemens Healthcare GmbH
These companies are competing not just on traditional lab-based tests but also on innovation launching biosensor-based devices, cloud platforms, and partnerships with pharmaceutical sponsors to embed monitoring in clinical trials.
Conclusion
The therapeutic drug monitoring market is on track for robust growth, rooted in the push toward individualized medicine and supported by technological advances. As the global healthcare system prioritizes treatment safety, efficacy, and patient-centered care, TDM is becoming an essential tool for clinicians to make informed dosing decisions.
Despite challenges related to cost, infrastructure, and skilled workforce, the outlook remains positive. The rise of decentralized sampling methods, automated lab systems, and biosensor-based platforms is lowering barriers and expanding access. Regulatory progress and improved payer recognition further strengthen the foundation for sustained market expansion.
Industry Related Reports:
ELISA Analyzer Market : The ELISA Analyzer Market Report provides a comprehensive overview of the industry, outlining segmentation by key operational and functional categories. It covers the type of operation (including automated ELISA analyzers and other variants), modality (such as bench-top and stand-alone/floor-standing systems), throughput levels (from low-throughput to additional capacity tiers), and assay formats (including sandwich ELISA and others). The report also examines detection technologies like colorimetric methods and more advanced options, as well as major applications such as vaccine development and additional use cases. Market forecasts are presented in terms of value (USD) across geographical regions, including North America and other global markets.
Aspergillosis Treatment Market : The Aspergillosis Treatment Market Report covers a comprehensive segmentation that includes infection type (such as allergic aspergillosis, chronic pulmonary aspergillosis, and others), drug class (including azoles, polyenes, and more), formulation (oral, intravenous, and others), distribution channel (hospital pharmacy, retail pharmacy, and additional channels), and patient category (HSCT patients, SOT recipients, and more), along with geographic breakdowns. The market forecasts are presented in terms of value (USD).
Aminophylline Market : The Aminophylline Market Report is Segmented by Route of Administration (Oral and Injection), Dosage Form (Tablet, Solution, and Extended-Release Capsule), Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, and More), End User (Hospitals, Clinics, and More), Distribution Channel (Hospital Pharmacies, and More), and Geography (North America, Europe and More). The Market Forecasts are Provided in Terms of Value (USD).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com https://www.mordorintelligence.com/
Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email: Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/